Events Partner Content SMi's 9th Annual Orphan Drugs & Rare Diseases Conference Orphan Drugs & Rare Diseases
Partner Content Partner Content Registration Opens for SMi’s 9th Annual Orphan Drugs & Rare ... Registration Opens for Orphan Drugs
Views & Analysis Patient access at risk: should stakeholders take an orchestr... Now is the time to work more harmoniously together to improve patient access to innovative treatments.
News Repligen builds in cell therapy with $1.5bn BioLife takeover Repligen has reached a deal to buy cell therapy specialist BioLife Solutions for $1.5bn, tapping into a market growing at breakneck speed.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
